Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

Movement Disorders : Official Journal of the Movement Disorder Society
A S WaltersK Sethi

Abstract

Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This double-blind, randomized, 12-week, multinational study compared the efficacy and safety of ropinirole and placebo in RLS. In total, 267 outpatients with moderate-to-severe RLS were randomly assigned to ropinirole (0.25-4.0 mg/day) or placebo, 1 to 3 hours before bedtime. The primary endpoint was the change in International Restless Legs Scale (IRLS) score at week 12. Key secondary endpoints were the percentage of patients showing significant improvement on the Clinical Global Impression-Improvement (CGI-I) scale at week 12 and changes in IRLS and CGI-I scale scores at week 1. Other measures included the Medical Outcomes Study sleep scale and Restless Legs Syndrome Quality of Life questionnaire. Improvements were significantly greater for ropinirole than placebo for change in IRLS score at week 12 (-11.2 [SE 0.76] vs. -8.7 [0.75], respectively; adjusted treatment difference -2.5 [95% confidence interval [CI], -4.6, -0.4], P = 0.0197); all key secondary endpoints; sleep and QoL parameters. Adverse events were typical for dopamine agonists; disease augmentation, although not directly assessed, was not reported ...Continue Reading

References

Jan 1, 1986·Clinical Neuropharmacology·J MontplaisirM A Bédard
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·A S Walters
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirP Lespérance
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·W Ondo
Apr 2, 1999·Neurology·J MontplaisirB Gomez-Mancilla
Jul 25, 2000·Archives of Internal Medicine·B PhillipsC Purvis
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·R P Allen, C J Earley
Jul 17, 2001·European Neurology·J UlfbergC Edling
Apr 10, 2002·JAMA : the Journal of the American Medical Association·B Timothy WalshMadelyn Gould
Jul 11, 2002·Pharmacopsychiatry·T C WetterT Bronisch
Dec 14, 2002·Mayo Clinic Proceedings·Allison M PritchettRaul E Espinosa
Nov 1, 2003·Sleep Medicine·L Ferini-Strambi
Nov 1, 2003·Sleep Medicine·Arthur S WaltersUNKNOWN International Restless Legs Syndrome Study Group
May 8, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M J AtkinsonUNKNOWN RLS Quality of Life Consortium

❮ Previous
Next ❯

Citations

Sep 1, 2006·Journal of Neurology·Wolfgang H JostOlivier Rascol
May 16, 2009·Journal of Neurology·Claudia TrenkwalderJuliane Winkelmann
Jul 25, 2006·Current Neurology and Neuroscience Reports·John C Morgan, Kapil D Sethi
Jul 10, 2007·Current Neurology and Neuroscience Reports·John C Morgan, Kapil D Sethi
May 25, 2013·Current Treatment Options in Neurology·Silvia Rios Romenets, Ronald B Postuma
Aug 28, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Mark J Buchfuhrer
Nov 1, 2003·Sleep Medicine·Arthur S WaltersUNKNOWN International Restless Legs Syndrome Study Group
Jun 10, 2010·Nature Reviews. Neurology·Claudia Trenkwalder, Walter Paulus
May 14, 2008·Southern Medical Journal·Eric Ball, Christine K Caivano
Aug 12, 2009·Clinical Neuropharmacology·Arthur S WaltersUNKNOWN XP045 Study Group
Feb 4, 2010·Clinical Neuropharmacology·Peter Hedera
Sep 22, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L VignatelliUNKNOWN EFNS Task Force
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J W Winkelman
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C Trenkwalder
Nov 16, 2006·Journal of General Internal Medicine·Roger KurlanCheryl Deeley
Mar 26, 2013·Postgraduate Medical Journal·Kavitha Nagandla, Somsubhra De
May 14, 2008·Annals of Family Medicine·William L BakerCraig I Coleman
Jun 1, 2006·Neuropsychiatric Disease and Treatment·Ruth ByrneK Ray Chaudhuri
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Clete A Kushida
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Philip M Becker
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Richard K Bogan
Mar 25, 2008·Therapeutics and Clinical Risk Management·Paul E Cotter, Shaun T O'Keeffe
Apr 28, 2010·Therapeutics and Clinical Risk Management·Daniel ErichsenDavid Gozal
Apr 20, 2006·Drugs·Miklos Z MolnarIstvan Mucsi
May 20, 2008·Drugs·Philippe Corcia, Vincent Meininger
May 20, 2008·CNS Drugs·Pankaj Satija, William G Ondo
Jan 1, 2006·The Libyan Journal of Medicine·Hani Benamer
Jun 17, 2011·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Daniel O LeeUNKNOWN XP053 Study Group
Dec 24, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Cynthia L Comella
Sep 23, 2014·Current Treatment Options in Neurology·William G Ondo
Jul 29, 2008·Revue neurologique·E KarroumI Arnulf
Jun 10, 2008·Journal of Women's Health·Karen Thomas, Carolyn B Watson
Mar 4, 2005·Current Neurology and Neuroscience Reports·Michael Thorpy
Oct 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Jens P ReeseRichard C Dodel
Apr 18, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·András SzentkirályiMárta Novák
Feb 6, 2008·Expert Opinion on Drug Metabolism & Toxicology·Giovanni MerlinoGian Luigi Gigli
May 20, 2008·Expert Opinion on Drug Metabolism & Toxicology·Shilpa Chitnis
Aug 9, 2005·Expert Opinion on Emerging Drugs·Stephany Fulda, Thomas C Wetter
Mar 4, 2008·Expert Opinion on Pharmacotherapy·Richard K Bogan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.